#healthcare

Roche to Buy 89bio for Up to $3.5 Billion in Obesity Push

Roche Holding AG will acquire biopharmaceutical company 89bio, Inc.

Roche Holding AG will acquire biopharmaceutical company 89bio, Inc. for up to $3.5 billion, the latest move by the Swiss drugmaker to enter the booming market to treat patients with obesity and related illnesses.

Bloomberg Markets • Sep 18, 06:25 AM

#acquisition #healthcare #markets #finance #bloomberg

CAP

Blackstone and TPG Revive Interest in Acquiring Medtech Hologic

Blackstone Inc.

Blackstone Inc. and TPG Inc. have revived their interest in acquiring medical device maker Hologic Inc., according to people familiar with the matter.

Bloomberg Markets • Sep 17, 08:18 PM

#healthcare #markets #finance #bloomberg #tech

CAP

Seqens Creditors Tap Paul Weiss as Cash Hits ‘Critical Point’

A group of creditors to Seqens SASU has tapped a legal adviser amid growing concerns over a potential cash crunch at the French pharmaceuticals firm.

A group of creditors to Seqens SASU has tapped a legal adviser amid growing concerns over a potential cash crunch at the French pharmaceuticals firm.

Bloomberg Markets • Sep 17, 12:35 PM

#healthcare #markets #bloomberg #finance

CAP

India Bulk Drug Makers Start Preparing for Ozempic Patent Expiry

Indian firms that make active pharmaceutical ingredients, or APIs, are gearing up to supply the basic ingredient that goes in making copies of Novo Nordisk A/S’s weight-loss drugs that are losing patent protection next year in several large markets.

Indian firms that make active pharmaceutical ingredients, or APIs, are gearing up to supply the basic ingredient that goes in making copies of Novo Nordisk A/S’s weight-loss drugs that are losing patent protection next year in several large markets.

Bloomberg Markets • Sep 17, 07:17 AM

#bloomberg #markets #finance #healthcare

CAP

Contrarian Fund Beating 97% of Peers Bets on Healthcare Laggards

A contrarian fund that beat 97% of its competitors has been buying up healthcare stocks in a bet that one of this year’s biggest laggards will turn into a winner.

A contrarian fund that beat 97% of its competitors has been buying up healthcare stocks in a bet that one of this year’s biggest laggards will turn into a winner.

Bloomberg Markets • Sep 17, 07:17 AM

#finance #healthcare #automotive #bloomberg #markets